Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout
28 déc. 2020 17h32 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BSTC, CBMG, CIT, and STND Buyouts
03 nov. 2020 13h15 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BioSpecifics Technologies Corp. (NASDAQ GS: BSTC) regarding possible breaches of...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, CBMG, CIT, and STND Mergers
19 oct. 2020 15h14 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: MyoKardia, Inc. (NASDAQ GS: MYOK) regarding possible breaches of fiduciary...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers
14 oct. 2020 13h14 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts
22 sept. 2020 15h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Immunomedics, Inc. (NASDAQ GS: IMMU) regarding possible breaches of fiduciary...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts
02 sept. 2020 20h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Principia Biopharma Inc. (NASDAQ GS: PRNB) regarding possible breaches of...
CELLULAR BIOMEDICINE GROUP, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
12 août 2020 16h38 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
Cellular Biomedicine Group Reports First Quarter 2016 Financial Results and Provides Business Highlights
09 mai 2016 16h01 HE
|
Cellular Biomedicine Group Inc.
– Reported Positive Clinical Data from Phase IIb trial of ReJoin® haMPC therapy– Expanded Stem Cell Platform with the Launch of New Allogeneic Clinical Trial– Closed Strategic Investment of $43.13...
Hagens Berman Alerts Investors in Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) of June 22nd Lead Plaintiff Deadline
07 mai 2015 08h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 7, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the June 22, 2015 lead plaintiff deadline in a class action...
Cellular Biomedicine Group Launches Development Program for Asthma Stem Cell Therapy
17 mars 2014 13h28 HE
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (OTCQB:CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...